Evidence map›Paper›PMID 33864388›Full record

ArticleInternational journal of dermatology2021

A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report.

Fouzia Hali, Houda Jabri, Soumiya Chiheb, Yassine Hafiani, Afak Nsiri

Open access · bronzeAbstract readCase ReportsLetter
In one paragraph

Article in International journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Systemic Lupus Erythematosus Risk: The Role of Environmental Factors.Rheumatic diseases clinics of North America · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Acute kidney injury in a patient with COVID-19: Answers.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  13. Rheumatological complications of Covid 19.Autoimmunity reviews · 2021
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fouzia HaliDepartment of Dermatology and Venerology, Ibn Rochd University Hospital, Casablanca, Morocco.
Houda JabriDepartment of Dermatology and Venerology, Ibn Rochd University Hospital, Casablanca, Morocco.ORCID https://orcid.org/0000-0002-2737-3398
Soumiya ChihebDepartment of Dermatology and Venerology, Ibn Rochd University Hospital, Casablanca, Morocco.
Yassine HafianiDepartment of Intensive Care Unit, Ibn Rochd University Hospital, Casablanca, Morocco.
Afak NsiriDepartment of Intensive Care Unit, Ibn Rochd University Hospital, Casablanca, Morocco.
Centre Hospitalier Universitaire Ibn Rochd · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Lupus Erythematosus, SystemicMacrophage Activation SyndromeHumansSARS-CoV-2

Identifiers

PMID33864388
PMCPMC8251349
OpenAlexW3155013713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.